Zai Lab and Cullinan Oncology Announce Strategic Collaboration and License Agreement for CLN-081 in Greater China Zai Lab and Cullinan Oncology Announce Strategic Collaboration and License Agreement for CLN-081 in Greater China Matt Burke2020-12-28T08:16:19-05:00December 28, 2020| Read More
Cullinan Oncology Completes $131.2 Million Series C Financing Cullinan Oncology Completes $131.2 Million Series C Financing Matt Burke2020-12-17T07:59:32-05:00December 17, 2020| Read More
Jon Wigginton MD Receives SITC Visionary Legacy Award Jon Wigginton MD Receives SITC Visionary Legacy Award Matt Burke2020-11-13T12:19:46-05:00November 13, 2020| Read More
Cullinan Pearl Announces Presentation of Preliminary Safety and Efficacy of CLN-081 in EGFR Exon 20 NSCLC Patients at ESMO Virtual Congress 2020 Cullinan Pearl Announces Presentation of Preliminary Safety and Efficacy of CLN-081 in EGFR Exon 20 NSCLC Patients at ESMO Virtual Congress 2020 Matt Burke2020-09-17T08:47:26-05:00September 17, 2020| Read More
Cullinan Oncology Announces First Patients Dosed with Drug Candidates from Cullinan Apollo and Cullinan Pearl Cullinan Oncology Announces First Patients Dosed with Drug Candidates from Cullinan Apollo and Cullinan Pearl Matt Burke2019-12-18T21:30:52-05:00December 18, 2019| Read More
